168 related articles for article (PubMed ID: 1330864)
1. M4 and M9 antibodies in the overlap syndrome of primary biliary cirrhosis and chronic active hepatitis: epitopes or epiphenomena?
Davis PA; Leung P; Manns M; Kaplan M; Munoz SJ; Gorin FA; Dickson ER; Krawitt E; Coppel R; Gershwin ME
Hepatology; 1992 Nov; 16(5):1128-36. PubMed ID: 1330864
[TBL] [Abstract][Full Text] [Related]
2. Anti-M4 antibodies in primary biliary cirrhosis react with sulphite oxidase, an enzyme of the mitochondrial inter-membrane space.
Klein R; Berg PA
Clin Exp Immunol; 1991 Jun; 84(3):445-8. PubMed ID: 2044223
[TBL] [Abstract][Full Text] [Related]
3. Antineutrophil nuclear antibodies (ANNA) in primary biliary cirrhosis: their prevalence and antigen specificity.
Orth T; Gerken G; Meyer Zum Büschenfelde KH; Mayet WJ
Z Gastroenterol; 1997 Feb; 35(2):113-21. PubMed ID: 9066101
[TBL] [Abstract][Full Text] [Related]
4. [Prognostic significance of antimitochondrial antibody profiles A-D in primary biliary cirrhosis].
Klein R; Berg PA
Dtsch Med Wochenschr; 1988 Oct; 113(40):1549-53. PubMed ID: 3168779
[TBL] [Abstract][Full Text] [Related]
5. [Significance of subtype pattern of antimitochondrial antibodies in primary biliary cirrhosis for prognostic parameters and response to ursodeoxycholic acid].
Wirth HP; Zala G; Meyenberger C; Ammann R
Schweiz Med Wochenschr; 1995 Apr; 125(15):750-4. PubMed ID: 7740290
[TBL] [Abstract][Full Text] [Related]
6. M4 and M9 autoantigens in primary biliary cirrhosis--a negative study.
Palmer JM; Yeaman SJ; Bassendine MF; James OF
J Hepatol; 1993 Jun; 18(2):251-4. PubMed ID: 7691927
[TBL] [Abstract][Full Text] [Related]
7. Characterization of a new mitochondrial antigen-antibody system (M9/anti-M9) in patients with anti-M2 positive and anti-M2 negative primary biliary cirrhosis.
Klein R; Berg PA
Clin Exp Immunol; 1988 Oct; 74(1):68-74. PubMed ID: 2464450
[TBL] [Abstract][Full Text] [Related]
8. Prevalence and characterization of neutrophil cytoplasmic antibodies in autoimmune liver diseases.
Mulder AH; Horst G; Haagsma EB; Limburg PC; Kleibeuker JH; Kallenberg CG
Hepatology; 1993 Mar; 17(3):411-7. PubMed ID: 8444414
[TBL] [Abstract][Full Text] [Related]
9. Is prevalence of PBC underestimated in patients with systemic sclerosis?
Norman GL; Bialek A; Encabo S; Butkiewicz B; Wiechowska-Kozlowska A; Brzosko M; Shums Z; Milkiewicz P
Dig Liver Dis; 2009 Oct; 41(10):762-4. PubMed ID: 19357001
[TBL] [Abstract][Full Text] [Related]
10. Demonstration of PDC-E1 subunits as major antigens in the complement-fixing fraction M4 and re-evaluation of PDC-E1-specific antibodies in PBC patients.
Berg CP; Stein GM; Klein R; Pascu M; Berg T; Kammer W; Priemer M; Nordheim A; Schulze-Osthoff K; Gregor M; Wesselborg S; Berg PA
Liver Int; 2006 Sep; 26(7):846-55. PubMed ID: 16911468
[TBL] [Abstract][Full Text] [Related]
11. Primary biliary cirrhosis. Inhibition of pyruvate dehydrogenase complex activity by autoantibodies specific for E1 alpha, a non-lipoic acid containing mitochondrial enzyme.
Fregeau DR; Roche TE; Davis PA; Coppel R; Gershwin ME
J Immunol; 1990 Mar; 144(5):1671-6. PubMed ID: 2106552
[TBL] [Abstract][Full Text] [Related]
12. Anti-52 kDa Ro(SSA) autoantibodies in different autoimmune diseases preferentially recognize epitopes on the central region of the antigen.
Dorner T; Feist E; Wagenmann A; Kato T; Yamamoto K; Nishioka K; Burmester GR; Hiepe F
J Rheumatol; 1996 Mar; 23(3):462-8. PubMed ID: 8832984
[TBL] [Abstract][Full Text] [Related]
13. Mitochondrial antigens and autoantibodies: from anti-M1 to anti-M9.
Berg PA; Klein R
Klin Wochenschr; 1986 Oct; 64(19):897-909. PubMed ID: 3537495
[TBL] [Abstract][Full Text] [Related]
14. Epitope mapping and reactivity of autoantibodies to the E2 component of 2-oxoglutarate dehydrogenase complex in primary biliary cirrhosis using recombinant 2-oxoglutarate dehydrogenase complex.
Moteki S; Leung PS; Dickson ER; Van Thiel DH; Galperin C; Buch T; Alarcon-Segovia D; Kershenobich D; Kawano K; Coppel RL
Hepatology; 1996 Mar; 23(3):436-44. PubMed ID: 8617422
[TBL] [Abstract][Full Text] [Related]
15. Enzyme inhibitory autoantibodies to pyruvate dehydrogenase complex in primary biliary cirrhosis: applications of a semiautomated assay.
Teoh KL; Rowley MJ; Zafirakis H; Dickson ER; Wiesner RH; Gershwin ME; MacKay IR
Hepatology; 1994 Nov; 20(5):1220-4. PubMed ID: 7927255
[TBL] [Abstract][Full Text] [Related]
16. Sjögren's syndrome and primary biliary cirrhosis: presence of autoantibodies to purified mitochondrial 2-OXO acid dehydrogenases.
Fujikura S; Davis PA; Prindiville T; Leung P; Fox RI; Gershwin ME
J Rheumatol; 1990 Nov; 17(11):1453-7. PubMed ID: 1703233
[TBL] [Abstract][Full Text] [Related]
17. Autoantibodies to BCOADC-E2 in patients with primary biliary cirrhosis recognize a conformational epitope.
Leung PS; Chuang DT; Wynn RM; Cha S; Danner DJ; Ansari A; Coppel RL; Gershwin ME
Hepatology; 1995 Aug; 22(2):505-13. PubMed ID: 7543435
[TBL] [Abstract][Full Text] [Related]
18. Detection of M2 antibodies in patients with recurrent urinary tract infection using an ELISA and purified PBC specific antigens. Evidence for a molecular mimicry mechanism in the pathogenesis of primary biliary cirrhosis?
Butler P; Hamilton-Miller J; Baum H; Burroughs AK
Biochem Mol Biol Int; 1995 Mar; 35(3):473-85. PubMed ID: 7773184
[TBL] [Abstract][Full Text] [Related]
19. Mixed types of chronic active hepatitis and primary biliary cirrhosis associated with the anti-phospholipid antibody syndrome: a case report.
Saeki R; Kaneko S; Terasaki S; Unoura M; Ogino H; Wakabayashi T; Kawara S; Nakanuma Y; Kobayashi K
Hepatogastroenterology; 1993 Oct; 40(5):499-501. PubMed ID: 8270244
[TBL] [Abstract][Full Text] [Related]
20. [Immunological characteristics of primary biliary cirrhosis patients].
Yan HP; Zhuang H; Liu YM; Feng X; Tan YF; Liu Y; Zhang X; Zhao CH
Zhonghua Gan Zang Bing Za Zhi; 2005 Jan; 13(1):12-6. PubMed ID: 15670483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
